Regeneron Pharmaceuticals logo
Regeneron Pharmaceuticals REGN
€ 706.70 -0.67%

Quartalsbericht 2024-Q3
hinzugefügt 31.10.2024

report update icon

Regeneron Pharmaceuticals Kennzahlen 2011-2024 | REGN

Kennzahlen Jährlich Regeneron Pharmaceuticals

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

P/E

25.3 19.3 8.3 14.8 17.4 18.5 33.7 40.3 68.1 120.4 67.6 22.1 -36.3

P/S

7.6 6.9 4.2 6.1 4.7 6.8 6.9 7.4 10.6 14.9 13.6 12.0 18.1

EPS

37.0 40.5 76.4 32.6 19.4 22.6 11.3 8.6 6.2 3.4 4.2 7.9 -2.5

EV (Enterprise Value)

105 B 87.1 B 70.5 B 55.9 B 38.8 B 46.8 B 42.2 B 38.1 B 44.4 B 42.6 B 29.2 B 17.2 B 8.41 B

EBITDA per Share

41.9 47.4 87.3 35.4 22.2 24.9 20.9 13.7 12.9 8.86 8.18 5.22 -1.92

EV/EBITDA

7.6 13.9 14.5 16.3 17.8 24.8 32.0 46.5 35.5 33.6 -45.1

PEG

0.92 0.57 0.15 0.58 -1.2 0.18 1.06 1.04 0.87 -5.99 -1.49 0.05 0.38

P/B

3.9 3.7 3.6 4.7 3.3 5.2 6.6 8.1 11.8 16.5 14.7 13.3 16.6

P/CF

21.8 16.7 9.4 19.9 18.4 25.0 39.0 37.5 66.3 102.2 67.1 -133.5 -40.5

ROE %

15.22 19.14 43.03 31.86 19.08 27.91 19.51 20.13 17.40 13.69 21.74 60.24 -45.65

ROA %

11.95 14.85 31.75 20.47 14.29 20.83 13.67 12.84 11.34 8.99 14.38 36.06 -16.75

ROCE %

15.58 20.91 47.67 32.44 17.39 24.63 27.26 23.22 26.09 26.06 28.66 23.88 -17.46

Current Ratio

4.7 4.5 3.8 2.8 3.7 4.5 3.8 2.6 3.6 3.3 6.0 7.4 4.4

DSO

153.0 170.4 103.9 111.9 124.0 122.0 122.7 121.0 130.6 131.7 154.7 183.5 84.4

DIO

- - - - 660.5 968.0 667.5 486.4 221.7 229.4 165.3 123.8 1173.6

DPO

- - - - 195.1 183.5 163.8 164.4 131.0 177.2 145.5 168.3 2401.2

Betriebszyklus

153.0 170.4 103.9 111.9 784.6 1090.0 790.2 607.4 352.3 361.1 319.9 307.3 1258.0

Finanzkreislauf

153.0 170.4 103.9 111.9 589.5 906.5 626.4 443.0 221.3 184.0 174.4 139.0 -1143.3

Alle Zahlen in USD-Währung

Kennzahlen Vierteljährlich Regeneron Pharmaceuticals

2024-Q3 2024-Q2 2024-Q1 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

EPS

12.4 13.25 6.7 9.48 9.05 7.64 - 12.31 7.9 9.12 - 15.37 29.51 10.58 10.9 7.98 8.19 5.69 7.25 6.12 1.77 4.23 7.58 5.5 5.12 4.44 1.62 3.64 3.66 2.36 2.41 2.53 1.88 1.74 1.49 2.04 1.89 0.74 0.89 0.89 0.89 0.89 0.98 1.44 0.89 1.02 4.92 2.02 0.81 0.12 -0.58 -0.68 -0.69 -0.49

EBITDA per Share

- - 8.03 - - 9.77 - 13.7 10.3 12.5 - 19.4 31.9 11.2 - 11.6 7.04 6.89 - 8.18 3.83 4.88 - 6.78 6.42 5.61 - 6.29 5.88 4.44 - 4.18 3.25 3.38 - 4.3 3.66 2.93 - 8.56 2.39 2.3 - 2.72 1.81 1.68 - 2.42 1.11 0.33 - -0.39 -0.5 -0.38

ROE %

16.37 15.83 14.23 17.70 19.79 19.87 15.14 24.60 27.92 44.29 39.25 49.68 47.86 35.51 31.86 28.58 26.98 20.59 19.08 21.31 22.06 26.61 27.91 21.37 20.90 20.91 19.50 22.37 22.00 20.10 20.13 18.68 18.48 19.40 17.40 16.70 14.47 12.68 14.11 15.51 19.21 20.16 21.71 54.21 62.35 64.04 59.91 11.47 -16.74 -35.77 -45.65 -12.84 -12.87 -8.94

ROA %

12.78 12.36 11.11 13.77 15.39 15.92 12.14 19.04 17.49 31.91 27.59 34.29 32.30 23.11 20.47 19.12 18.74 14.82 14.29 15.93 16.48 19.87 20.83 15.82 15.18 14.91 13.67 15.32 14.69 13.08 12.84 11.98 11.93 12.59 11.34 10.92 9.52 8.40 9.36 10.29 12.73 13.34 14.38 33.71 38.12 38.85 36.06 9.41 -4.50 -12.91 -16.75 -4.71 -4.72 -3.28

ROCE %

15.06 15.27 15.51 18.43 19.68 20.81 17.39 28.10 33.09 49.85 42.12 51.67 50.52 34.35 21.86 28.51 25.62 22.51 13.83 20.99 21.49 25.75 20.74 29.85 31.81 33.66 25.08 33.23 32.27 29.87 22.11 32.85 35.43 38.31 27.93 36.39 57.96 56.99 57.65 61.32 41.14 40.78 28.07 44.32 48.44 47.36 25.06 13.02 -15.26 -34.71 -32.89 -12.03 -12.42 -8.44

Current Ratio

4.6 4.6 4.7 4.4 4.6 4.6 4.5 4.4 - 4.1 3.8 3.7 3.4 3.1 2.8 2.8 2.8 2.8 4.0 4.0 4.0 4.0 3.9 3.9 3.9 3.9 3.3 3.3 3.3 3.3 2.8 2.8 2.8 2.8 2.9 2.9 2.9 2.9 3.0 3.0 3.0 2.9 3.0 3.0 3.0 3.0 2.5 2.5 2.5 2.5 1.6 1.6 1.6 1.6

DSO

145.0 140.7 156.8 145.3 147.9 150.7 - 86.2 77.3 167.3 - 164.5 99.2 149.5 155.0 163.7 192.3 155.1 102.8 109.9 121.5 127.1 81.6 94.5 97.8 98.5 88.7 93.6 95.5 99.7 99.9 100.5 101.1 94.8 95.8 92.5 105.3 99.3 84.1 93.0 101.3 111.3 117.7 120.3 156.9 143.2 130.6 126.6 177.8 122.3 21.0 25.1 23.9 -

DIO

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

DPO

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Betriebszyklus

145.0 140.7 156.8 145.3 147.9 150.7 - 86.2 77.3 167.3 - 164.5 99.2 149.5 155.0 163.7 192.3 155.1 102.8 109.9 121.5 127.1 81.6 94.5 97.8 98.5 88.7 93.6 95.5 99.7 99.9 100.5 101.1 94.8 95.8 92.5 105.3 99.3 84.1 93.0 101.3 111.3 117.7 120.3 156.9 143.2 130.6 126.6 177.8 122.3 21.0 25.1 23.9 -

Finanzkreislauf

145.0 140.7 156.8 145.3 147.9 150.7 - 86.2 77.3 167.3 - 164.5 99.2 149.5 155.0 163.7 192.3 155.1 102.8 109.9 121.5 127.1 81.6 94.5 97.8 98.5 88.7 93.6 95.5 99.7 99.9 100.5 101.1 94.8 95.8 92.5 105.3 99.3 84.1 93.0 101.3 111.3 117.7 120.3 156.9 143.2 130.6 126.6 177.8 122.3 21.0 25.1 23.9 -

Alle Zahlen in USD-Währung